S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:LPTX

Leap Therapeutics (LPTX) Stock Forecast, Price & News

$0.70
-0.15 (-17.64%)
(As of 06/6/2023 ET)
Compare
Today's Range
$0.69
$0.85
50-Day Range
$0.30
$0.93
52-Week Range
$0.27
$1.86
Volume
2.00 million shs
Average Volume
889,563 shs
Market Capitalization
$83.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.80

Leap Therapeutics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
299.9% Upside
$2.80 Price Target
Short Interest
Bearish
9.65% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.57) to ($0.38) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.52 out of 5 stars

Medical Sector

880th out of 981 stocks

Pharmaceutical Preparations Industry

421st out of 464 stocks


LPTX stock logo

About Leap Therapeutics (NASDAQ:LPTX) Stock

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Receive LPTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

LPTX Stock News Headlines

This NASDAQ Stock Is The Amazon Of Medical Supply
This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now
Leap Therapeutics (LPTX) Receives a Buy from Mizuho Securities
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update
What 5 Analyst Ratings Have To Say About Leap Therapeutics
Leap Therapeutics (NASDAQ:LPTX) Announces Earnings Results
Mizuho Securities Remains a Buy on Leap Therapeutics (LPTX)
Robert W. Baird Keeps Their Buy Rating on Leap Therapeutics (LPTX)
Leap Therapeutics, Inc. (LPTX)
See More Headlines

LPTX Price History

LPTX Company Calendar

Last Earnings
5/15/2023
Today
6/06/2023
Next Earnings (Estimated)
8/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LPTX
Fax
N/A
Employees
36
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.80
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+289.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-54,600,000.00
Pretax Margin
-14,214.93%

Debt

Sales & Book Value

Annual Sales
$1.50 million
Book Value
$0.59 per share

Miscellaneous

Free Float
105,918,000
Market Cap
$85.84 million
Optionable
Not Optionable
Beta
0.67

Key Executives

  • Doug E. Onsi
    President, CEO, CFO, Secretary & Treasurer
  • Augustine J. Lawlor
    Chief Operating Officer
  • Cynthia Sirard
    Chief Medical Officer
  • Jason S. Baum
    Chief Scientific Officer
  • Michael Haas
    Head-Research













LPTX Stock - Frequently Asked Questions

Should I buy or sell Leap Therapeutics stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Leap Therapeutics in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LPTX shares.
View LPTX analyst ratings
or view top-rated stocks.

What is Leap Therapeutics' stock price forecast for 2023?

3 equities research analysts have issued 12 month target prices for Leap Therapeutics' shares. Their LPTX share price forecasts range from $2.00 to $4.00. On average, they predict the company's share price to reach $2.80 in the next twelve months. This suggests a possible upside of 289.5% from the stock's current price.
View analysts price targets for LPTX
or view top-rated stocks among Wall Street analysts.

How have LPTX shares performed in 2023?

Leap Therapeutics' stock was trading at $0.45 at the beginning of 2023. Since then, LPTX shares have increased by 59.8% and is now trading at $0.7189.
View the best growth stocks for 2023 here
.

When is Leap Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 11th 2023.
View our LPTX earnings forecast
.

How were Leap Therapeutics' earnings last quarter?

Leap Therapeutics, Inc. (NASDAQ:LPTX) posted its quarterly earnings data on Monday, May, 15th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.09) by $0.23.

What other stocks do shareholders of Leap Therapeutics own?
What is Leap Therapeutics' stock symbol?

Leap Therapeutics trades on the NASDAQ under the ticker symbol "LPTX."

Who are Leap Therapeutics' major shareholders?

Leap Therapeutics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Baker BROS. Advisors LP (6.22%), Samsara BioCapital LLC (5.61%), Price T Rowe Associates Inc. MD (1.29%), Key Client Fiduciary Advisors LLC (1.29%), Knott David M Jr (0.47%) and Renaissance Technologies LLC (0.38%).
View institutional ownership trends
.

How do I buy shares of Leap Therapeutics?

Shares of LPTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Leap Therapeutics' stock price today?

One share of LPTX stock can currently be purchased for approximately $0.72.

How much money does Leap Therapeutics make?

Leap Therapeutics (NASDAQ:LPTX) has a market capitalization of $85.84 million and generates $1.50 million in revenue each year. The company earns $-54,600,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis.

How can I contact Leap Therapeutics?

Leap Therapeutics' mailing address is 47 THORNDIKE STREET SUITE B1-1, CAMBRIDGE MA, 02141. The official website for the company is www.leaptx.com. The company can be reached via phone at (617) 714-0360 or via email at heather@argotpartners.com.

This page (NASDAQ:LPTX) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -